A check performed on all the children suffering from atypical progressive acute kidney disorder revealed that 74% of them have ethylene glycol and diethylene glycol in their blood. The medicine, consumed by more than 50% of the patients, contain the two chemicals. Earlier, Chairwoman of the Food and Drug Control Agency (Badan Pengawas Obat dan Makanan – “BPOM”), Dr. Ir. Penny K. Lukito, MCP, reported that the ethylene and diethylene glycol content in the ingredients of liquid oral medication exceeds the 0.1%, even as much as 50%.
Read: BPOM accuses two pharma firms of negligence in medicinal syrup manufacturing
dr. Syahril reports that death from acute kidney disorder has lowered after the antidote fomepizole was administered to patients. The results of the biopsy of patients’ kidneys showed that clinical improvement occurred after the administration of the antidote. “Fomepizole distribution is now expanded to hospitals that treat acute kidney disorder patients. A total of 246 fomepizole injection vials are imported from various countries, mostly from donations – Singapore, Australia, Canada, and Japan. 200 of them are already distributed to 41 hospitals in 34 provinces di Indonesia,” he said. During the event, dr. Syahril underlines how acute kidney failure is different from chronic kidney failure. “Therefore, when the toxin is gone after the antidote is administered, patients can be totally cured,” he said. (est)